MIRA INFORM REPORT

 

 

Report Date :

08.01.2011

 

IDENTIFICATION DETAILS

 

Name :

MY HEALTHSKAPE MEDICALS PRIVATE LIMITED

 

 

Registered Office :

4/ 425 A, Sharma Industrial Estate, Walbhat Road, Goregaon – 400 063, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2009

 

 

Date of Incorporation :

04.04.2003

 

 

Com. Reg. No.:

11-139877

 

 

CIN No.:

[Company Identification No.]

U33100MH2003PTC139877

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMM18869E

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trader of Medical Equipments i.e. Ophthalmology Equipments.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (29)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 123000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. Trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for small business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION PARTED BY

 

Name :

Mr. Rajesh Chandan

Designation :

Accounts Executive

Contact No.:

91-9322132134

Date :

07.11.2011

 

 

LOCATIONS

 

Registered Office :

4/ 425 A, Sharma Industrial Estate, Walbhat Road, Goregaon – 400 063, Maharashtra, India

Tel. No.:

91-22-26862626 / 26862828 / 26862929

Mobile No.:

91-9920072281 (Mr. Sachin)

Fax No.:

91-22-26862929 / 66994477

E-Mail :

sachin@myhealthskape.com

info@myhealthskape.com

Website :

www.myhealthskape.com

Area :

2000 sq ft

Location :

Owned

 

 

Branch Office :

Care of VIV Chemical, 2907, Phase II, GIDC, Vapi

Location :

Rented

 

 

DIRECTORS

 

As on 29.09.2010

Name :

Mr. Manish Bhachoo

Designation :

Director

Address :

71, Varsh Building, Goregaon, Mumbai – 400 062, Maharashtra, India

Date of Birth/Age :

16.09.1968

Qualification :

BE

Date of Appointment :

04.04.2003

 

 

Name :

Mrs. Santosh J. Bhachoo

Designation :

Director

Address :

71, Jawahar Nagar, Goregaon, Mumbai – 400 062, Maharashtra, India

Date of Birth/Age :

10.06.1935

Qualification :

HSC

Date of Appointment :

04.04.2003

 

 

Name :

Mr. Sameer Paigankar

Designation :

Director

Address :

RH4, O-7, Sector – 6, Navi Mumbai – 400 703, Maharashtra, India

Qualification :

B. Pharm

Date of Appointment :

01.07.2005

 

 

Name :

Mrs. Sheela S. Paigankar

Designation :

Director

Address :

RH4, O-7, Sector – 6, Navi Mumbai – 400 703, Maharashtra, India

Qualification :

B. Pharm

Date of Appointment :

01.07.2005

 

 

KEY EXECUTIVES

 

Name :

Mr. Rajesh Chandan

Designation :

Accounts Executive

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 29.09.2010

Names of Shareholders

 

No. of Shares

 

Manish Bhachoo

 

1574900

Santosh J. Bhachoo

 

17490

Prachi Singh Bachoo

 

100

Sameer Paigankar

 

78755

Sheela S. Paigankar

 

78755

Total

 

1750000

 

As on 29.09.2010

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Trader of Medical Equipments i.e. Ophthalmology Equipments.

 

 

Products :

 

 

Agencies Held :

  • Wavelight – Germany
  • Moria – France
  • Tomey – USA
  • Hanshin – Korea

 

 

Exports :

 

Products :

Equipments

Countries :

Sri Lanka, Nepal

 

 

Imports :

 

Products :

Ophthalmology Equipments

Countries :

USA, Germany, Japan, Korea

 

 

Terms :

 

Selling :

L/C, Cash and Credit (30 Days)

 

 

Purchasing :

L/C, Cash and Credit (30 Days)

 

 

GENERAL INFORMATION

 

Suppliers :

  • Ellex Medical Pty Limited
  • Aditya Jyot Eye Hospital
  • Hanshin Medical Company Limited
  • Moria S.A.
  • Okay Industries
  • My Healthskape
  • Prudential Enterprises
  • Zlemer 

 

 

Customers :

End Users, OEM’s 

 

  • Akal Eye Hospital
  • Aditya Jyot Eye Hospital
  • Apollo Hospbl Ent
  • Dhaml Eye Care Hospital
  • Disha Eye Hospital
  • Paulomi Super Specialty Hospitals
  • Punjab Lasik Centre
  • Sai Surya Netra Seva
  • Shroff Eye Hospital
  • NIO – Pune
  • Max Healthcare Institute

 

 

No. of Employees :

100 (Approximately)

 

 

Bankers :

  • ICICI Bank Limited, Land Mark Race Course Circle, Alkapuri, Baroda – 390 015, Gujarat, India
  • ABN Amro Bank
  • HDFC Bank
  • The Saraswat Co-Operative Bank Limited, Pratiksha Apartment, Opposite Filmistan Studio, S.V. Road, Goregaon (West), Mumbai – 400 062, Maharashtra, India

 

 

Facilities :

Secured Loans :

 

As on 31.03.2009

Rs. in Millions

As on 31.03.2008

Rs. in Millions

ABN-AMRO Loan against Medical Equipment

Total Investments due for n d 12 months Rs.2.118 millions.

NA

1.522

ICICI Bank Nariman Point Branch Overdraft against Stock-in-Trade , Sundry Debtors, Office premises and residential flat

NA

19.524

HDFC Bank against logan car

fatal installments due for next 12 months Rs.0.121 million

Sarco term loan 8272

NA

0.417

 

 

1.258

 

 

 

Total

NA

22.721

 

 

 

Financial Institution:

Religare Finvest Limited, 19, Nehru Place, New Delhi-110 019, Delhi, India

 

 

Banking Relations :

-

 

 

Auditors :

 

Name :

H.K. Shah and Associates

Chartered Accountants

Address :

Office No. 507 and 516, Anant Deep Chambers, 273 I 77, Narshi Natha street, Bhat Bazer, Mumbai - 400 089, Maharashtra, India

Tel. No.:

91-22-23773258

Mobile No.:

91-9323773258

 

 

CAPITAL STRUCTURE

 

As on 29.09.2010

Authorised Capital :

No. of Shares

Type

Value

Amount

1750000

Equity Shares

Rs.10/- each

Rs.17.500 millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

1750000

Equity Shares

Rs.10/- each

Rs.17.500 millions

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2009

31.03.2008

31.03.2007

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

17.500

17.500

0.111

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

13.359

8.007

7.798

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

30.859

25.507

7.909

LOAN FUNDS

 

 

 

1] Secured Loans

21.092

22.721

3.384

2] Unsecured Loans

9.285

0.000

1.078

TOTAL BORROWING

30.377

22.721

4.462

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

61.236

48.228

12.371

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

10.448

7.233

9.205

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.025

0.025

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

50.397

58.111

35.814

 

Sundry Debtors

96.131

75.994

80.225

 

Cash & Bank Balances

28.817

55.757

1.033

 

Other Current Assets

26.805

19.629

0.000

 

Loans & Advances

5.455

11.671

12.568

Total Current Assets

207.605

221.162

129.640

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

118.529

110.034

 

Other Current Liabilities

154.396

52.631

11.100

 

Provisions

2.482

9.075

5.390

Total Current Liabilities

156.878

180.235

126.524

Net Current Assets

50.727

40.927

3.116

 

 

 

 

MISCELLANEOUS EXPENSES

0.036

0.043

0.050

 

 

 

 

TOTAL

61.236

48.228

12.371

 

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2009

31.03.2008

31.03.2007

 

SALES

 

 

 

 

 

Income

NA

280.070

123.227

 

 

Other Income

NA

12.914

5.955

 

 

TOTAL                                     (A)

NA

292.984

129.182

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Purchases

NA

261.182

110.248

 

 

Administrative Expenses

NA

50.205

47.771

 

 

Increase/(Decrease) in Finished Goods

NA

(22.297)

(35.814)

 

 

TOTAL                                     (B)

NA

289.090

122.205

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

NA

3.894

6.977

 

 

 

 

 

Less

TAX                                                                  (H)

NA

3.685

3.312

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

9.759

0.209

3.665

 

 

 

 

 

 

IMPORTS

NA

98.764

NA

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

 

 

 

Particulars

 

 

31.03.2010

31.03.2009

Sales Turnover (Approximately)

 

400.000

320.000

 

Expected Sales (2010-2011) : Rs.500.000 millions

KEY RATIOS

 

PARTICULARS

 

 

31.03.2009

31.03.2008

31.03.2007

PAT / Total Income

(%)

NA

0.07

2.84

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

NA

1.39

5.66

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA

1.70

5.03

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA

0.15

0.88

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

6.07

7.96

16.56

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.32

1.23

1.02

LOCAL AGENCY FURTHER INFORMATION

 

Details of Sundry Creditors: (Partial Details)

 

Particulars

31.03.2009

(Rs. in millions)

31.03.2008

(Rs. in millions)

31.03.2007

(Rs. in millions)

Sundry Creditors for Goods

Hanshin Medical Company Limited

NA

 

1.483

 

1.483

Moria S.A.

NA

1.475

1.209

Okay Industries

NA

12.793

3.998

Wavellington AG Spares

NA

42.686

1.447

Prudential Enterprises

NA

4.452

2.514

 

 

 

 

Sundry Creditors for Expenses

AFL Dachser Private Limited

 

NA

 

0.322

 

--

Airtel a/c 13511424

NA

0.002

--

Aremex India Private Limited

NA

0.003

0.011

Basix Forex and Financial Solution

NA

0.025

0.025

Blue Dart Express

NA

0.273

0.174

 

Note:

The situation of the registered office of the company was changed from 11, Udyog Bhavan, Near Railway Station, Goregaon East, Mumbai – 400 063, Maharashtra to the present address w.e.f. 04.09.2009.

 

WORKING RESULTS

During the year, the Company has made Profit of Rs.9.759 millions.

 

TRADE REFERENCES:

 

  • Bombay City Eye Institutes
  • Cure Sight Laser Centre

 

Bankers Charges Report as per Registry

 

Corporate identity number of the company

U33100MH2003PTC139877

Name of the company

MY HEALTHSKAPE MEDICALS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

11, Udyog Bhavan, Near Railway Station, Goregaon East, Mumbai – 400 063, Maharashtra, India

This form is for

Modification of charge

Charge identification number of the modified 

Creation of charge

Type of charge

Movable Property

Particular of charge holder

Religare Finvest Limited, 19, Nehru Place, New Delhi-110 019, Delhi, India

Nature of description of the instrument creating or modifying the charge

Loan cum Hypothecation Agreement

Date of instrument Creating the charge

Rs.26.12.2009

Amount secured by the charge

Rs.5.050 millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest

18.5 % p.a.

 

Terms of Repayment

Tenure : 1 Year

12 EMIs of Rs.0.464 million

 

Margin

nil

Extent and Operation of the charge

First charge over the asset hypothecated

Short particulars of the property charged

Excimer Laser -  Allegretto Wave Eye - Q 400 Hz

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.37

UK Pound

1

Rs.70.04

Euro

1

Rs.58.93

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

29

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

 

-

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.